Talecris Biotherapeutics, Inc.

Talecris Biotherapeutics, Inc. is a biopharmaceutical company established in 2004, with the slogan "Crafting Life-Saving Plasma Protein Therapies Since 2004". Being one of the largest producers and marketers of plasma-derived protein therapies globally, the company operates in the biotechnology and healthcare industries. Their core focus lies in developing, producing, marketing, and distributing therapies that positively impact the lives of individuals afflicted with chronic and acute, often life-threatening conditions such as chronic inflammatory demyelinating polyneuropathy (CIDP), primary immune deficiencies (PI), alpha-1 antitrypsin deficiency, bleeding disorders, infectious diseases, and severe trauma.

They source their products from human plasma, which is collected from their plasma collection centers or purchased from third parties, primarily situated in the United States. As of now, no specific details about their last investment or investors have been disclosed.